Startups
At Novacyt, we pride ourselves on concentrating our expertise on specific market needs. Offering a comprehensive and developing portfolio of quality products, backed by proven supply and delivery services, to ensure the highest possible standards of customer service around the world. Our passion is for customer-centric solutions that advance the science behind diagnostics. This fuels our drive to deliver products that save lives and help in the fight against infectious disease. We offer an increasing portfolio of in-vitro diagnostic tests, utilising molecular and protein detection technologies – supporting healthcare and disease prevention across the globe in the clinical and life science sectors. Deep strengths in product development, commercialisation, contract design, and manufacturing ensure quality products and robust supply. Our Group has specialist experience and expertise throughout our business units: Primerdesign, Microgen Bioproducts, IT-IS international, and Lab21 Healthcare – creating solutions for the diagnostics industry, supplying an extensive range of high-quality assays and reagents worldwide.
Overview
Location
France, Ile-of-France, Vélizy-Villacoublay
Employees
201-500
Total raised
$4.7M
Founded date
2005
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 21
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 4, 2022 | Novacyt : Long Term Incentive Plan 2022 Performance Share Awards | Paris, France and Camberley, UK - 4 February 2022 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it is launching a new Performance Share Awards programme for executive... |
| Oct 19, 2021 | Novacyt : Results of Annual General Meeting | Paris, France and Camberley, UK - 19 October 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its Annual General Meeting (AGM), comprising ordinary and extraordinary gen... |
| Oct 17, 2021 | Novacyt : 2021 AGM | Novacyt S.A. ("Novacyt", the "Company" or the "Group") Notice of AGM Paris, France and Camberley, UK - 29 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical di... |
| Sep 30, 2021 | Novacyt : R&D update | Including launch of two new tests to differentiate between COVID-19 and common winter viruses, and between COVID-19 variants Paris, France and Camberley, UK - 30 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international... |
| Sep 29, 2021 | Novacyt : Notice of AGM | Paris, France and Camberley, UK - 29 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that following the announcement earlier today the Company's rescheduled Annual... |
| Sep 28, 2021 | Novacyt : 2021 AGM | Novacyt S.A. ("Novacyt", the "Company" or the "Group") Notice of AGM Paris, France and Camberley, UK - 20 August 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagn... |
| Sep 27, 2021 | Novacyt : Half year 2021 results | Solid underlying financial performance and well-positioned for continued growth Paris, France and Camberley, UK - 27 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announce... |
| Sep 16, 2021 | Novacyt : Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results | Paris, France and Camberley, UK - 16 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the proposed accounting treatment of the ongoing DHSC dispute on its unaudited... |
| Sep 8, 2021 | Novacyt : Company's activity during FY20 | NOVACYT Limited company with registered capital of 4,708,416.54 euros Registered office: 13 avenue Morane Saulnier - 78140 Vélizy-Villacoublay 491 062 527 Versailles Trade and Companies Register (hereinafter the "Company" or "... |
Show more
Reviews 0
FAQ about Novacyt
When was Novacyt founded?
Novacyt was founded in 2005.
How much funding has Novacyt raised?
Novacyt has raised $4.7M in total across 1 funding round.
What has the press written about Novacyt?
Parsers VC has collected 21 articles mentioning Novacyt, among them “Novacyt : Long Term Incentive Plan 2022 Performance Share Awards” (Feb 4, 2022) and “Novacyt : Results of Annual General Meeting” (Oct 19, 2021).
Is Novacyt still active?
Yes, Novacyt is active; its latest activity on Parsers VC dates from Mar 15, 2023.